Cytotoxic ribonucleases and chimeras in cancer therapy
- PMID: 8472310
Cytotoxic ribonucleases and chimeras in cancer therapy
Abstract
Ribonucleases serve as cytotoxic agents during host defense and physiological cell death pathways. In bacteria, higher plants, and mammals, ribonucleases appear to bind cells, enter the cytosol where they degrade RNA, and kill the target cell. This process functions in interstrain competition in bacteria, in the death of incompatible pollen in higher plants, and likely plays a role in the antiparasitic and anticancer activity of eosinophils in man. One can alter the target cell specificity of RNases by coupling them to new cell-binding domains. Chemically coupling RNases to new binding moieties or fusing RNase genes to antibody genes results in chimeric molecules with specified cell-type cytotoxicity. Thus, one can target one's own host defense cytotoxins to select cell populations. This allows the use of human proteins, instead of plant and bacterial toxins, in the construction of immunotoxins. RNases also can be engineered to kill cells by cytosolic expression or to kill viruses by packaging into viruses. Engineering RNases into cell-type-specific cytotoxins may result in a new class of therapeutic reagents. We review a number of interesting physiological cell cytotoxicity pathways utilizing RNases and then describe the recent results on engineering RNases for therapeutic use.
Similar articles
-
[Why ribonucleases cause death of cancer cells].Mol Biol (Mosk). 2005 Jan-Feb;39(1):3-13. Mol Biol (Mosk). 2005. PMID: 15773542 Review. Russian.
-
Ribonucleases of different origins with a wide spectrum of medicinal applications.Biochim Biophys Acta. 2011 Jan;1815(1):65-74. doi: 10.1016/j.bbcan.2010.09.001. Epub 2010 Sep 16. Biochim Biophys Acta. 2011. PMID: 20843477 Review.
-
Rational immunotherapy with ribonuclease chimeras. An approach toward humanizing immunotoxins.Cell Biophys. 1992 Aug-Dec;21(1-3):121-38. doi: 10.1007/BF02789483. Cell Biophys. 1992. PMID: 1285324 Review.
-
Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition.Protein Eng Des Sel. 2006 Jan;19(1):37-45. doi: 10.1093/protein/gzi073. Epub 2005 Oct 21. Protein Eng Des Sel. 2006. PMID: 16243897
-
Targeted therapeutic RNases (ImmunoRNases).Expert Opin Biol Ther. 2009 Jan;9(1):79-95. doi: 10.1517/14712590802631862. Expert Opin Biol Ther. 2009. PMID: 19063695 Review.
Cited by
-
Identification and evaluation of a major cytotoxin of A. fumigatus.Mol Cell Biochem. 1997 Feb;167(1-2):89-97. doi: 10.1023/a:1006823706119. Mol Cell Biochem. 1997. PMID: 9059985
-
Loss of a histidine residue at the active site of S-locus ribonuclease is associated with self-compatibility in Lycopersicon peruvianum.Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6511-4. doi: 10.1073/pnas.91.14.6511. Proc Natl Acad Sci U S A. 1994. PMID: 8022814 Free PMC article.
-
A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure.Nucleic Acids Res. 2000 Jun 15;28(12):2375-82. doi: 10.1093/nar/28.12.2375. Nucleic Acids Res. 2000. PMID: 10871370 Free PMC article.
-
Adenovirus-mediated hPNPase(old-35) gene transfer as a therapeutic strategy for neuroblastoma.J Cell Physiol. 2009 Jun;219(3):707-15. doi: 10.1002/jcp.21719. J Cell Physiol. 2009. PMID: 19202553 Free PMC article.
-
RNase inhibition of human immunodeficiency virus infection of H9 cells.Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6012-6. doi: 10.1073/pnas.91.13.6012. Proc Natl Acad Sci U S A. 1994. PMID: 8016107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources